LabCompass

Jered Myslinski

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
RNA regulation and diseaseImmune cells in cancerRNA and protein synthesis mechanismsCRISPR and Genetic EngineeringSingle-cell and spatial transcriptomics

Publications

25

Citations

552

Est. group size

~1

Recurring co-author estimate

Active years

11

Publishing since 2015

Research summary
AI-generated

Jered Myslinski works in biochemistry and molecular biology, studying how genes and proteins are regulated in disease, with published work on the signaling pathways behind acute myeloid leukemia (a blood cancer) and how tumors resist targeted drugs. The broader research profile spans RNA regulation, cancer immunology, and gene-editing tools such as CRISPR. This work aims to understand disease mechanisms at the molecular level and identify ways to overcome treatment resistance.

RNA regulation and diseaseCancer immunology and leukemiaRNA and protein synthesisCRISPR and genetic engineeringSingle-cell and spatial transcriptomics

Publication activity rose to a peak around 2021-2022 and has since settled to a steady pace of about two papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 2.2/year recently
172018: 1 publication182019: 3 publications192020: 2 publications202021: 4 publications212022: 5 publications5222023: 2 publications232024: 2 publications242025: 2 publications2526
Recent publications
Publishes in
  • bioRxiv (Cold Spring Harbor Laboratory)×5
  • Journal of the American Society of Nephrology×4
  • Journal of Clinical Investigation×2
  • PMC×2
  • eLife×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile